Exploring Thiazolo[3,2-a]pyrimidine Derivatives: Synthetic Strategies and Biological Implications

Thiazolopyrimidines are heterocyclic analogs of purine bases that are formed from the combination of two heterocycles: thiazole and pyrimidine. This results in the formation of a scaffold shared by both heterocyclic rings, where a nitrogen atom exchanges one carbon atom at the ring junction. Numerous studies have revealed the successful synthesis of various substituted thiazolopyrimidines using a range of synthetic methods, including one-pot multicomponent techniques, microwave irradiation, and environmentally friendly approaches. Extensive research has focused on different thiazolopyrimidine analogs to identify promising compounds with potential therapeutic applications, given their established pharmacological properties. Some novel thiazolopyrimidine derivatives have demonstrated significant activities, including analgesic, anticonvulsant, antiparkinsonian, antiinflammatory, HIV-1 reverse transcriptase inhibition, anticancer, acetylcholinesterase inhibition, and antiviral effects. It highlights the importance of further exploring the synthesis of novel derivatives within this series, particularly those that may exhibit biological activity. This review provides a comprehensive resource for researchers in the fields of medicinal chemistry and drug discovery, offering valuable insights into the synthetic methodologies and therapeutic potential of thiazolo[3,2- a]pyrimidine derivatives within the timeframe of 1990 to 2025.